Trial intelligence / Profile preview

Vitamin D Supplementation in Clomiphene-Resistant PCOS

NCT04916925Phase 2Unknown

Start
Aug 2021
Primary completion
Sep 2021
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
01

Overview

Phase 2, open-label, single-arm trial of vitamin d in polycystic ovary syndrome (PCOS). Primary endpoint: Number of the ovulated follicles. Status: unknown.

02

Drugs

vitamin d
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on NCT04916925.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04916925.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call